Join
Live feed
·
INSIDERFilingvia Quantisnow
Indivior Pharmaceuticals Inc. logo

Chief Financial Officer Preblick Ryan covered exercise/tax liability with 87,597 shares and converted options into 86,949 shares, decreasing direct ownership by 0.20% to 317,292 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDV (Indivior Pharmaceuticals Inc.) and more on Quantisnow.